Chi Van Dang, M.D., Ph.D

Dr. Dang earned his Ph.D. in Chemistry from Georgetown University and his M.D. degree from the Johns Hopkins University School of Medicine. His pioneer work helped define the complex functions of the MYC oncogene, a central switch in human cancer, whose mutation or aberrant expression is associated with many types of cancer and their altered metabolism. Dr. Dang is Scientific Director of the Ludwig Institute for Cancer Research and a professor at The Wistar Institute. Prior to that, he was Director of the Abramson Cancer Center of the University of Pennsylvania, Professor of Medicine, and the John H. Glick Professor. He is a member of the National Academy of Medicine, a fellow of the American Academy of Arts & Sciences, and chairs the National Cancer Institute’s Board of Scientific Advisors.